logo
Ultrasound Devices Market Forecast at $15.23 Billion by 2033: Technological Advancements and Rising Demand for Point-of-Care Diagnostics Driving Industry Growth

Ultrasound Devices Market Forecast at $15.23 Billion by 2033: Technological Advancements and Rising Demand for Point-of-Care Diagnostics Driving Industry Growth

Yahoo25-03-2025
Includes Detailed Profiles of Industry Giants: GE Healthcare, Siemens Healthcare, Philips, Canon, Fujifilm Holdings Corporation, Samsung Medison Co. (Samsung Electronics Co.), and Hitachi
Ultrasound Devices Market
Dublin, March 25, 2025 (GLOBE NEWSWIRE) -- The "Ultrasound Devices Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" has been added to ResearchAndMarkets.com's offering.The Ultrasound Devices market is expected to grow from US$ 9.31 billion in 2024 to US$ 15.23 billion in 2033 at a compound annual growth rate (CAGR) of 5.61% during the forecast period of 2025 to 2033. Growth in the ultrasound devices market can be attributed to advancements in ultrasound technology, growing healthcare awareness, an increase in chronic diseases, and the need for non-invasive diagnostic procedures in developed as well as emerging markets.
Technological Advancements in Ultrasound ImagingTechnologies have improved their performance and functionality of ultrasound significantly. Advances like 3D/4D imaging, portable ultrasound machines, and AI-powered diagnostics are improving image quality, shortening examination times, and enhancing the accuracy of diagnoses. Such innovations have made ultrasound devices more accessible and practical, thus pushing their adoption in various healthcare settings. Miniaturized and handheld ultrasound devices allow for point-of-care diagnostics, making it easier to perform real-time imaging in remote or resource-limited areas, thus fueling market growth.Rising Prevalence of Chronic DiseasesThe rising prevalence of chronic diseases, including cardiovascular disorders, cancer, and liver diseases, is a key driver for the growth of the ultrasound devices market. Ultrasound imaging is critical in diagnosing, monitoring, and managing these conditions. As the global population ages, the demand for non-invasive, reliable diagnostic tools like ultrasound devices continues to rise. Early detection and continuous monitoring of chronic conditions are vital for better treatment outcomes, further boosting the market's growth, especially in developed and emerging markets.Rising Demand for Point-of-Care DiagnosticsThe trend of point-of-care (POC) diagnostics is significantly driving the market for ultrasound devices. As healthcare providers focus more on providing immediate and efficient care, portable ultrasound devices have become indispensable in emergency rooms, outpatient clinics, and rural areas. These portable and compact devices enable point-of-care imaging for healthcare professionals, ensuring quicker diagnosis and treatment. Emphasis on quick and efficient service delivery is creating a huge market for portable ultrasound devices at non-hospital setups.Advanced Ultrasound Systems are Highly ExpensiveAdvanced ultrasound machines with 3D/4D imaging and AI capabilities have the largest impact on this market. Since high-end, modern ultrasound technology requires huge purchases and maintenance expenses, many facilities with smaller scale health setups as well as growing economies are challenged. Such state-of-the-art models limit adoption on a much wider scale due to their steep cost. This encourages many hospitals and health clinics to go for simple models due to lower price scales. Moreover, the high cost of training for the operation of sophisticated systems increases the overall cost, which hampers market growth.Regulatory and Reimbursement IssuesThe ultrasound devices market is affected by regulatory approval and reimbursement policies. In many countries, stringent regulations require that ultrasound devices undergo rigorous testing and certification before they can be marketed. Such processes delay product launches and increase costs. Apart from this, regional reimbursement policies are different for ultrasound procedures, so most of the expenses related to modern devices or even diagnostic services remain uncovered. Poor reimbursement rates lead to reduced use of advanced ultrasound technologies among health care providers. This also impairs the market growth.Ultrasound Therapeutic Systems MarketThe Ultrasound Therapeutic Systems market is rising rapidly with increased demand for pain management and other musculoskeletal disorders, where non-invasive treatment is increasingly being used along with rehabilitation programs. These systems work by applying high-frequency sound waves to tissues, thereby inducing healing, reducing inflammation, and improving circulation. They are often used in physiotherapy and sports medicine for conditions such as tendonitis, muscle strains, and joint pain. Market growth is also fueled by advancements in ultrasound technology, the rise of preventive healthcare, and increasing awareness of non-invasive treatments that provide patients with effective, safe alternatives to surgery.Compact/Handheld Ultrasound Devices IndustryCompact and handheld ultrasound devices are transforming the industry by providing portable, cost-effective, and easy-to-use alternatives to traditional, bulky ultrasound machines. These devices allow healthcare providers to perform real-time diagnostics at the point of care, improving patient outcomes and reducing wait times. Compact ultrasound devices are particularly beneficial in emergency settings, rural areas, and field hospitals with limited access to large imaging equipment. Minimization and battery development have made such portable devices better in efficiency and do not allow a compromise of the image clarity. Their inexpensiveness along with user friendliness is factors for their wider usage in diversified areas, namely primary care, obstetrics, musculoskeletal therapy, and even veterinary care.Color Ultrasound Equipment MarketThe Color Ultrasound Equipment market is growing fast due to ever-increasing requirements for advanced image solutions that have high-resolution visualization of blood circulation and tissue arrangements in real-time. Color Doppler ultrasound systems enhance diagnostic accuracy by visualizing blood circulation, aiding in the detection of cardiovascular conditions, tumors, and vascular diseases. Advancements in imaging technology drive the market, the rising prevalence of chronic diseases, and the growing focus on non-invasive diagnostic tools. Additionally, color ultrasound equipment's expanding use in obstetrics, cardiology, and emergency medicine further fuels market growth globally.Cardiology Ultrasound MarketThe Cardiology Ultrasound Market is growing due to the increasing prevalence of cardiovascular diseases and the demand for non-invasive diagnostic tools. Ultrasound imaging, especially echocardiography, is widely used in assessing heart conditions, including valve disorders, heart failure, and coronary artery disease. Technological advancements in imaging quality, portability, and integration of AI for enhanced diagnostics are driving market growth. This, combined with an increasingly elderly population, will further enhance the growth of the cardiology ultrasound market in the global level.Diagnostic Centers Ultrasound Device IndustryThe industry of Diagnostic Centers Ultrasound Devices is increasing with the rise in demand for non-invasive diagnostic devices. Ultrasound devices are essential in diagnostic centers for imaging organs, tissues, and blood flow, aiding in detecting conditions such as tumors, heart disease, and pregnancy. Technological advancements, such as portable and high-resolution ultrasound systems, enhance diagnostic capabilities. Additionally, the growing focus on early detection, increased awareness of preventive healthcare, and a rise in chronic diseases contribute to the widespread adoption of ultrasound devices in diagnostic centers globally.Canada Ultrasound Devices MarketThe demand for non-invasive diagnostic tools in the healthcare sector is increasing, thereby driving the growth of the Canada Ultrasound Devices Market. The ultrasound devices are used for a wide range of applications, such as obstetrics, cardiology, and musculoskeletal imaging. The recent advancements in technology have increased their application in other fields of medicine. Growing chronic diseases and aging population further support the growth of the market. In addition, the increasing emphasis on early detection and the use of ultrasound devices in clinics and diagnostic centers are driving the growth of the ultrasound devices market in Canada.France Ultrasound Devices MarketThe France Ultrasound Devices Market is growing steadily with the advancement in ultrasound technology and the rising healthcare needs. Ultrasound devices are used for diagnostic imaging in obstetrics, cardiology, musculoskeletal conditions, and emergency medicine. The demand for portable and high-resolution ultrasound systems is increasing due to their convenience and ability to provide real-time results. The aging population and the growing prevalence of chronic diseases, such as cardiovascular disorders, are also driving market expansion. France's healthcare infrastructure and increasing adoption of non-invasive diagnostic tools are further driving the ultrasound devices market.China Ultrasound Devices MarketThe China Ultrasound Devices Market is expanding rapidly with growing healthcare demand, technological advancements, and an increasing aging population. Ultrasound devices are widely used for diagnostic imaging in various medical fields, such as obstetrics, cardiology, and musculoskeletal conditions. With the increased prevalence of chronic diseases and the need for early detection, ultrasound technology is becoming more widespread. Moreover, the government's emphasis on developing health infrastructure and increasing the availability of medical equipment in rural areas is driving the growth of the market. The increasing availability of affordable, portable ultrasound systems increases accessibility, making ultrasound devices more accessible across China.UAE Ultrasound Devices MarketThe UAE Ultrasound Devices Market is growing rapidly with the increased demand for advanced diagnostic tools in the healthcare sector. The use of ultrasound devices in non-invasive obstetrics, cardiology, and musculoskeletal imaging is quite widespread. A growing population, rising prevalence of chronic diseases, and increased emphasis on early detection and preventive healthcare are the main drivers for the market. Advances in technology, such as portable and high-definition ultrasound systems, are improving access and diagnostic accuracy. Alongside the above factors, the world-class infrastructure of healthcare within the UAE coupled with investment in medical technology propels the market for ultrasound devices.
Key Company Analysis: Overview, Recent Developments, Revenue Analysis
GE Healthcare
Siemens Healthcare
Philips
Canon Inc.
Fujifilm Holdings Corporation
Samsung Medison Co. Ltd. (Samsung Electronics Co. Ltd.)
Hitachi Ltd.
Key Attributes
Report Attribute
Details
No. of Pages
140
Forecast Period
2024-2033
Estimated Market Value (USD) in 2024
$9.31 Billion
Forecasted Market Value (USD) by 2033
$15.23 Billion
Compound Annual Growth Rate
5.6%
Regions Covered
Global
Key Topics Covered1. Introduction2. Research Methodology3. Executive Summary4. Market Dynamics4.1 Growth Drivers4.2 Challenges5. Global Ultrasound Device Market6. Market Share6.1 By Product6.2 By Portability6.3 By Display Type6.4 By Application6.5 By End Users6.6 By Country7. Product7.1 Diagnostic Ultrasound Systems7.2 Therapeutic Ultrasound Systems8. Portability8.1 Trolley/Cart-based Ultrasound Devices8.2 Compact/Handheld Ultrasound Devices9. Display Type9.1 Color Ultrasound Devices9.2 Black & White (B/W) Ultrasound Device10. Application10.1 Radiology/General Imaging10.2 Cardiology10.3 Gynecology10.4 Vascular10.5 Urology10.6 Others11. End Users11.1 Hospitals11.2 Surgical Centers11.3 Diagnostic Centers11.4 Maternity Centers11.5 Ambulatory Care Centers11.6 Academic Institutions12. Country12.1 North America12.1.1 United States12.1.2 Canada12.2 Europe12.2.1 France12.2.2 Germany12.2.3 Italy12.2.4 Spain12.2.5 United Kingdom12.2.6 Belgium12.2.7 Netherlands12.2.8 Turkey12.3 Asia-Pacific12.3.1 China12.3.2 Japan12.3.3 India12.3.4 South Korea12.3.5 Thailand12.3.6 Malaysia12.3.7 Indonesia12.3.8 Australia12.3.9 New Zealand12.4 Latin America12.4.1 Brazil12.4.2 Mexico12.4.3 Argentina12.5 Middle East & Africa12.5.1 Saudi Arabia12.5.2 UAE12.5.3 South Africa13. Porter's Five Analysis13.1 Bargaining Power of Buyers13.2 Bargaining Power of Suppliers13.3 Degree of Rivalry13.4 Threat of New Entrants13.5 Threat of Substitutes14. SWOT Analysis14.1 Strength14.2 Weakness14.3 Opportunity14.4 Threat15. Company AnalysisFor more information about this report visit https://www.researchandmarkets.com/r/kodu4q
About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
Ultrasound Devices Market
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

AI is already replacing thousands of jobs per month, report finds
AI is already replacing thousands of jobs per month, report finds

Yahoo

time27 minutes ago

  • Yahoo

AI is already replacing thousands of jobs per month, report finds

Artificial intelligence is already replacing thousands of jobs each month as the U.S. job market struggles amid global trade uncertainty, a report has found. The outplacement firm Challenger, Gray, and Christmas said in a report filed this week that in July alone the increased adoption of generative AI technologies by private employers led to more than 10,000 lost jobs. The firm stated that AI is one of the top five reasons behind job losses this year, CBS News noted. On Friday, new labor figures revealed that employers only added 73,000 jobs in July, a much worse result than forecasters expected. Companies announced more than 806,000 job cuts in the private sector through July, the highest number for that period since 2020. The technology industry is seeing the fiercest cuts, with private companies announcing more than 89,000 job cuts, an increase of 36 percent compared to a year ago. Challenger, Gray, and Christmas found that more than 27,000 job cuts have been directly linked to artificial intelligence since 2023. "The industry is being reshaped by the advancement of artificial intelligence and ongoing uncertainty surrounding work visas, which have contributed to workforce reductions," the firm said. The impact of artificial intelligence is most severe among younger job seekers, with entry-level corporate roles usually available to recent college graduates declining by 15 percent over the past year, according to the career platform Handshake. The use of 'AI' in job descriptions has also increased by 400 percent during the last two years. There are other reasons for recent job losses, with more than 292,000 roles having been terminated following cuts connected to the Department of Government Efficiency, previously led by Elon Musk, a former close ally of President Donald Trump, Challenger, Gray, and Christmas found. Senior vice president Andrew Challenger said in a statement, 'We are seeing the federal budget cuts implemented by DOGE impact non-profits and health care in addition to the government.' Amid the rising costs associated with tariffs, layoffs are also increasing in the retail sector, according to the firm. Through July, retailers announced more than 80,000 cuts, an increase of close to 250 percent compared to the same period last year. "Retailers are being impacted by tariffs, inflation, and ongoing economic uncertainty, causing layoffs and store closures. Further declines in consumer spending could trigger additional losses," said the firm. White collar workers are among those at highest risk of having their jobs wiped out by AI, executives have warned. But Challenger said early last month, 'There are roles that can be significantly changed by AI right now, but I'm not talking to too many HR leaders who say AI is replacing jobs,' he added, according to NBC News. In June, Amazon CEO Andy Jassy said AI would 'reduce our total corporate workforce as we get efficiency gains.' But he didn't specify a timeframe. Last month, The Wall Street Journal reported that Ford CEO Jim Farley would replace 'literally half of all white-collar workers in the U.S.' But experts argue that AI is currently affecting the job market in roundabout ways, such as many companies coming under intense pressure to cut costs because of the uncertain economic climate pushed by Trump's tariff policy and concerns about increasing inflation. As such, some companies are spending money on AI software instead of hiring new staff. The CEO of The Josh Bersin Company workforce consultancy, Josh Bershin, told NBC News,'There's basically a blank check to go out and buy these AI tools.' 'Then they go out and say, as far as head count: No more hiring. Just, 'stop.' So that immediately freezes the job market,' he added.

CSX Corporation (CSX) Might Be Bought Too, Says Jim Cramer
CSX Corporation (CSX) Might Be Bought Too, Says Jim Cramer

Yahoo

timean hour ago

  • Yahoo

CSX Corporation (CSX) Might Be Bought Too, Says Jim Cramer

We recently published . CSX Corporation (NASDAQ:CSX) is one of the stocks Jim Cramer recently discussed. CSX Corporation (NASDAQ:CSX)'s shares have gained 9.8% year-to-date, and like other railroads, it has also been a frequent feature of Cramer's morning show. The CNBC TV host has discussed the firm in the context of the emerging trend of mergers in the railroad industry. His previous comments about CSX Corporation (NASDAQ:CSX) have hinted at hesitance at the firm's management for the deal. This time, after railroad giant Union Pacific announced that it would acquire Norfolk Southern, Cramer wondered whether Burlington North would buy CSX: 'But the fact is, they were never going to go against each other. That's not, the rails, stop doing that years ago. So, I look at this and I say, Vena makes sense. The only issue is, okay, so, does Burlington North have to go buy CSX? And they do.' Copyright: meinzahn / 123RF Stock Photo Previously, the CNBC TV host discussed CSX Corporation (NASDAQ:CSX) and the dynamics of the railroad industry: 'Well look they have a direct corridor, CSX, direct corridor connects South East Mexico, Texas, US Southeast. That's Union Pacific. Why would you let that happen? Why would you make it so that you have two railroads that have that area and not make it so that there's one. And I think Joe Hinrichs, the CEO of CSX, might not want this deal. He's young. He took over the railroad. He just got there.' While we acknowledge the potential of CSX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

An Army Contract Fueled Red Cat Stock's 911% Surge in 13 Months: Is RCAT Still a Buy?
An Army Contract Fueled Red Cat Stock's 911% Surge in 13 Months: Is RCAT Still a Buy?

Yahoo

timean hour ago

  • Yahoo

An Army Contract Fueled Red Cat Stock's 911% Surge in 13 Months: Is RCAT Still a Buy?

Red Cat Holdings Inc. (RCAT) has stunned investors with an extraordinary 911% stock price surge over the past 13 months, trading at $8.19 as of July 31, 2025. This dramatic rise coincides with a string of transformative milestones, chief among them a major U.S. Army contract to supply cutting-edge reconnaissance drones — a catalyst that's redefining both the company's fortunes and its outlook in the defense sector. Just about 13 months ago, on June 7, RCAT was a penny stock trading at $0.81. This turnaround and continued growth show the incredible momentum and potential of the stock. More News from Barchart Morgan Stanley Says Nvidia Has 'Exceptional' Strength. Should You Buy NVDA Stock Here? With UnitedHealth Under DOJ Investigation, Should You Buy, Sell, or Hold UNH Stock Now? As Trump Says He Wants Tesla to 'THRIVE,' How Should You Play TSLA Stock? Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. Why RCAT Stock Soared: The Army's SRR Contract The breakthrough came as Red Cat was chosen for the U.S. Army's prestigious Short Range Reconnaissance (SRR) program. Under this multi-year deal, the Army could acquire up to 5,880 Black Widow drones — small, advanced, reconnaissance-focused systems built by the company's subsidiary Teal Drones and listed on the Pentagon's Blue UAS procurement roster. This certification both validates Red Cat's technology and opens the door for federal agency sales, giving it a crucial edge over rivals. The SRR contract is set to be a game-changer for Red Cat's top line, with management projecting 2025 revenues between $80 million and $120 million, compared to just $1.63 million reported for the quarter ending March 31, 2025. SRR-related sales alone are expected to contribute $25–65 million to FY2025 revenue, with additional growth from ongoing Black Widow, Edge 130 VTOL drone, and FANG drone sales — all supported by growing government orders. Multi-Domain Growth and Operational Momentum Red Cat is fortifying its position through a diversified product portfolio covering aerial and soon maritime (unmanned surface vessel) platforms, significantly lowering reliance on any single contract. Key manufacturing partnerships, like with Empirical Systems Aerospace (ESAero) — an AS9100-certified defense supplier — ensure production quality and scalability. To streamline operations and ramp up output, Red Cat is deploying advanced software solutions from Palantir Technologies (PLTR). This includes Warp Speed (for supply chain optimization) and VNav (for drone autonomy in GPS-denied environments), bolstering both performance and strategic value to military buyers. The company's strong cash position — boosted by over $75 million raised through equity offerings in April and June 2025 — guarantees the resources needed for rapid scale-up and timely fulfillment of large backlogs. Market Disconnect and High Short Interest Despite these fundamentals, RCAT shares have experienced volatile swings, with a 52-week high of $15.27 and low of $1.66, leaving the current valuation below some analyst forecasts. The stock's short interest recently topped 15.86 million shares, which accounts for over 20% of the public float, and sets up the potential for a significant short squeeze if the company continues to exceed expectations. Analyst sentiment remains firmly bullish, with a consensus 12-month target price of $13.00 — a roughly 55% upside from current levels. The disconnect between Red Cat's operational progress and its share price presents a compelling opportunity for investors able to look past short-term volatility. Are New Highs Coming? Red Cat Holdings' extraordinary 911% gain in just over a year is powered by structural shifts in the defense drone market and a landmark Army contract. With robust financial backing, scalable production, and a multi-domain strategy, Red Cat is poised for continued high growth as U.S. military and agency adoption of unmanned systems accelerates. Should the company deliver on its ambitious projections, the coming quarters could see further upward pressure on RCAT's already surging shares Red Cat vs. the Competition Red Cat distinguishes itself in the defense drone sector by focusing on tactical reconnaissance drones and integrating advanced software partnerships (notably with Palantir) to enhance both manufacturing and drone autonomy. Its military contracts have resulted in a clear turning point for the stock. Compared to peers like Unusual Machines (UMAC), DroneShield (DRSHF), and Draganfly (DPRO), Red Cat stands out for its agility, U.S.-centric supply chain, and rapid revenue growth from breakout military orders, while many larger rivals spread efforts across broader product lines and geographies. Some direct competitors, such as AvePoint, have higher revenue, but trade at lower valuations and lack the same near-term growth catalysts tied to U.S. defense spending. Red Cat does face significant operational scaling risks and remains unprofitable, but its focused product strategy, robust partnerships, and recent fundraising leave it better positioned for upside than many in the sector, as long as execution remains strong. RCAT vs. Unusual Machines Unusual Machines has rapidly emerged as a high-upside player in the U.S. drone sector, gaining 40% in a single trading session after the Pentagon announced a sweeping initiative to ramp up domestic drone production. UMAC has now gained 422% over the past 12 months. The company focuses on manufacturing and distributing U.S.-made drone components and complete systems, aiming to serve both consumer and defense markets with NDAA-compliant offerings. Recent strategic acquisitions — such as Rotor Lab Pty Ltd for high-performance motors — and a $48.5 million capital raise have underpinned its expansion, including the launch of a 17,000-square-foot manufacturing hub in Orlando. Unusual Machines' strengths are agility, dual sourcing options, and a focus on supplying critical components listed on the Pentagon's Blue UAS Framework, positioning it for major new procurement cycles and growing institutional interest. However, as a small-cap firm competing with much larger defense contractors, it carries significant execution and volatility risks, as is typical for early-stage industry disruptors. Notably, however, it does have a valuation that is only a fraction of RCAT, sitting around $285 million to Red Cat's $840 million. But it also has substantially less revenue and fewer growth prospects, meaning Red Cat is likely sitting as a better play overall. RCAT vs. DroneShield DroneShield, based in Australia and listed on the ASX, specializes in counter-drone (C-UAS) technologies designed to detect, track, and neutralize hostile unmanned systems. Its product suite — including the DroneGun, DroneSentry, and radar/electronic warfare integrations — serves military, government, and critical infrastructure clients worldwide. DroneShield has seen substantial demand growth due to the escalating prevalence of drone threats in both military and civilian contexts, leading to robust order flow from NATO countries, Asia-Pacific clients, and U.S. agencies. Revenue expansion and new contract wins have underlined its strong international footprint, and its established partnerships with defense organizations set it apart as a major global supplier in the C-UAS space. Still, its business remains exposed to the episodic nature of government procurement and technological arms races in the drone sector. DroneShield isn't a direct competitor, but it does highlight the ongoing growth and demand of the sector. DroneShield is a little over twice the size of Red Cat, but is seeing similarly massive growth and achieved profitability in its most recent quarter. RCAT vs. Draganfly Draganfly, a U.S.-listed company, designs and manufactures advanced drone platforms, sensors, and data analytics solutions for public safety, agriculture, industrial inspections, and defense applications. Known for its proprietary payloads and turnkey UAV systems, Draganfly is attempting to differentiate itself with custom engineering and a focus on regulatory compliance for security-sensitive missions. It is winning small- to mid-scale contracts and developing partnerships with North American agencies and the Ukrainian government, leveraging its capacity to rapidly deploy drones in crisis zones. Draganfly's challenges include intense competition from legacy aerospace firms and a relatively small revenue base, though it is targeting rapid organic and acquisition-driven expansion to capture a greater share of the burgeoning commercial and tactical drone market. Unlike others on this list, Draganfly hasn't received nearly the same hype or momentum. In recent months, DPRO has delivered only modest gains. Given its smaller footprint and lack of overall momentum, it's likely the least compelling on this list. On the date of publication, Caleb Naysmith did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store